These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2967144)

  • 1. A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes.
    Lewis KS; Bradley C; Knight G; Boulton AJ; Ward JD
    Diabet Med; 1988 Apr; 5(3):235-42. PubMed ID: 2967144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of the Continuous Subcutaneous Insulin Infusion-Related Quality-of-Life (CSII-QOL) Scale.
    Sakane N; Murata T; Tone A; Kato K; Kimura M; Kawashima S; Sawaki H; Hirota Y; Okada A; Kuroda A; Matsuhisa M; Watanabe T; Suganuma A; Nirengi S; Toyoda M
    Diabetes Technol Ther; 2020 Mar; 22(3):216-221. PubMed ID: 31638420
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
    Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
    Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
    Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
    Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
    Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
    Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatment.
    Joubert M; Morera J; Vicente A; Rod A; Parienti JJ; Reznik Y
    J Diabetes Sci Technol; 2014 Sep; 8(5):1005-10. PubMed ID: 24876454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions in Type 1 Diabetes Mellitus with or Without the Use of Insulin Pump: An Online Study.
    Benioudakis ES
    Curr Diabetes Rev; 2020; 16(8):874-880. PubMed ID: 31057119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient perceptions of using the OmniPod system compared with conventional insulin pumps in young adults with type 1 diabetes.
    Lebenthal Y; Lazar L; Benzaquen H; Shalitin S; Phillip M
    Diabetes Technol Ther; 2012 May; 14(5):411-7. PubMed ID: 22283640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences and real life management of insulin pump therapy in adults with type 1 diabetes.
    Quirós C; Jansà M; Viñals C; Giménez M; Roca D; Escarrabill J; Garcia F; Pérez S; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):117-123. PubMed ID: 30076125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and metabolic control in patients with diabetes mellitus type 1 treated by continuous subcutaneous insulin infusion or multiple daily insulin injections.
    Hoogma RP; Spijker AJ; van Doorn-Scheele M; van Doorn TT; Michels RP; van Doorn RG; Levi M; Hoekstra JB
    Neth J Med; 2004 Nov; 62(10):383-7. PubMed ID: 15683093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.
    Hoogma RP; Hammond PJ; Gomis R; Kerr D; Bruttomesso D; Bouter KP; Wiefels KJ; de la Calle H; Schweitzer DH; Pfohl M; Torlone E; Krinelke LG; Bolli GB;
    Diabet Med; 2006 Feb; 23(2):141-7. PubMed ID: 16433711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic and psychosocial factors associated with continuous subcutaneous insulin infusion in adolescents with type 1 diabetes.
    Cortina S; Repaske DR; Hood KK
    Pediatr Diabetes; 2010 Aug; 11(5):337-44. PubMed ID: 19761529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous subcutaneous insulin infusion in diabetes mellitus type 1 and 2: lower HbA1c-values and a high level of patient satisfaction].
    de Borst JM; Berghout A
    Ned Tijdschr Geneeskd; 2003 Oct; 147(41):2021-5. PubMed ID: 14587146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients.
    Schottenfeld-Naor Y; Galatzer A; Karp M; Josefsberg Z; Laron Z
    Isr J Med Sci; 1985 Oct; 21(10):822-8. PubMed ID: 3908396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring.
    Arias P; Kerner W; Zier H; Navascués I; Pfeiffer EF
    Diabetes Care; 1985; 8(2):134-40. PubMed ID: 3888562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS).
    Little SA; Leelarathna L; Walkinshaw E; Tan HK; Chapple O; Lubina-Solomon A; Chadwick TJ; Barendse S; Stocken DD; Brennand C; Marshall SM; Wood R; Speight J; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JA
    Diabetes Care; 2014 Aug; 37(8):2114-22. PubMed ID: 24854041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.